FilingSEC EDGARSCHEDULE 13D/ASAB Biotherapeutics, Inc. filed Form SCHEDULE 13D/AAug 10, 2026, 16:27 ET · SEC acceptedSummaryFiling infoView sourceFiling contentPlease check the source for details.Related companiesSAB Biotherapeutics, Inc.SABSView stockLikeCommentsRepostShareComments —CommentLoading comments…
Comments —
Loading comments…